Combined Synopsis/SolicitationPosted Sep 23, 2026·Responses due Sep 25, 2026

6515--541-26-3-250-0303 - Olympus BX43 Pathology Microscope Brand Name Only Small Business Set-Aside

Veterans Affairs · 250-NETWORK CONTRACT OFFICE 10 (36C250)

Stage
Open solicitation
NAICS
339112
Value
Not stated
Solicitation
36C25026Q1066
Set-aside
Small Business Set Aside - Total
PSC
6515
Place
Cleveland, OH, USA
Contact
Kevin Peeples (Kevin.peeples@va.gov)
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 36C25026Q1066 in this department, oldest first.

Early notice
None posted
Solicitation
  • Sep 23, 2026 · this notice
    Combined Synopsis/Solicitation
Award
Not yet. Typical award: Oct 7, 2026 to Oct 28, 2026, middle of the range Oct 15, 2026.
Measured from 366 past solicitations at Veterans Affairs, Department of with NAICS 339112 that later posted an award (middle half of cases, counted from Sep 23, 2026).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Decide bid or no bid before the response deadline.
  • Look at the past winners for likely competitors and teaming partners.
  • Follow the opportunity to hear about amendments and the award.

What the notice says

Combined Synopsis/Solicitation Notice *= Required Field Combined Synopsis/Solicitation Notice DESCRIPTION This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation document will not be issued. This solicitation is issued as an RFQ. The solicitation … (show all)

document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2023-01. This solicitation is a Small Business set-aside. The associated North American Industrial Classification System (NAICS) code for this procurement is 339112. The FSC/PSC is 6515. The NCO 10 for Cleveland VA Medical Center is seeking to purchase the Olympus BX Microscope for the Cytology Department. This solicitation closes on September 25, 2026 @ 13:00 AM. Quotes should be submitted to Kevin Peeples kevin.peeples@va.gov Please reference 36C25026Q1066 1. Contracting Officer s Representative (COR NA 2. CONTRACT TITLE: BX43-1-3 Cytology Microscopes 3. BACKGROUND The Department of Veterans Affairs Northeast Ohio Healthcare System (VANEOHS) has an immediate requirement for the procurement of two (2) brand name Evident (formerly Olympus) BX43-1-3 cytology microscopes, inclusive of the True Color LED light source compatible with BX43F, BX46F, and BX63F platforms, and all required Original Equipment Manufacturer (OEM) components and accessories necessary for full clinical activation and use. The requested microscopes are additional units to the currently deployed Evident BX-series microscopes within the Cytology Section of Pathology & Laboratory Management Services (PALMS). The laboratory s diagnostic workflows, digital imaging systems, standardized operating procedures, educational protocols, and preventative maintenance programs are fully based upon the Evident BX-series platform. The Cytology laboratory s diagnostic workflows, digital imaging systems, standardized operating procedures, educational platforms, and preventative maintenance programs are built upon the BX-series architecture. The Cytology Section performs high-resolution visualization and evaluation of: Cellular morphology Cytological abnormalities Microbiological organisms Inflammatory processes Neoplastic pathologies These diagnostic evaluations are mission-critical to accurate, timely, and actionable patient diagnoses. This acquisition is required to maintain full operational capacity, mitigate diagnostic backlog, maximize utilization of existing Government-owned assets, and ensure uninterrupted cytopathology services. 4. SCOPE The Contractor shall provide two (2) new, current production BX43-1-3 microscopes, inclusive of the True Color LED light source and all requested and associated OEM components, accessories, modules, assemblies, and consumables required for immediate clinical deployment within the Cytology Section. The Contractor shall provide on-site installation, configuration, and operational verification of all microscopes and associated OEM components at the Louis Stokes Cleveland VA Medical Center, Pathology & Laboratory Management Services Cytology Section. Installation shall include full assembly, alignment of optical components, calibration of the illumination system, verification of mechanical stage functionality, confirmation of imaging integration (if applicable), and validation of overall system performance for clinical diagnostic use. All equipment shall be fully operational and ready for immediate patient care application upon completion of installation. Any deficiencies identified during installation or inspection shall be corrected by the Contractor at no additional cost to the Government prior to final acceptance. The microscopes and components shall meet or exceed the following operational, optical, interoperability, and performance requirements: Optical and Imaging Performance: UIS2 infinity-corrected optical system Plan Apochromat or Plan Fluorite objectives optimized for cytology applications High numerical aperture objectives suitable for oil immersion cytopathology 100x oil immersion capability Wide field number (FN 22 or greater) High-resolution visualization suitable for evaluation of cellular morphology, cytologic abnormalities, infectious organisms, and neoplastic processes OEM camera adapter compatibility for integration with existing digital imaging systems Illumination System: True Color LED light source compatible with BX43F, BX46F, and BX63F Daylight-balanced illumination to support accurate cytologic color interpretation Flicker-free, stable output LED lifespan 20,000 hours Intensity memory function Uniform illumination across full field of view Ergonomic and Mechanical Features: Ergonomic observation tube with adjustable inclination Low-position coaxial focus knobs Coarse and fine focus with tension adjustment Precision mechanical stage with fine movement control Stage inserts compatible with cytology slide preparation Configuration optimized for prolonged microscopic review Required OEM Accessories and Components: The Contractor shall provide all OEM components necessary to ensure full functionality and activation, including but not limited to: Proprietary stage inserts Light modules Camera adapters Immersion oil kits (OEM approved) Dust covers Power cords Calibration and setup materials Required mounting hardware Any additional OEM components necessary for clinical operation All components must be new, OEM-manufactured, and fully compatible with existing Evident BX-series microscopes currently deployed within the laboratory. Interoperability Requirements: The Cytology Section is standardized on the Evident BX-series microscope platform. All diagnostic workflows, imaging protocols, training materials, and maintenance programs are built upon this system. The requested microscopes are additional to the currently deployed fleet and must: Integrate seamlessly with existing BX-series equipment Maintain optical consistency across the microscope fleet Preserve manufacturer warranty protections Support existing service contracts and maintenance protocols Require no retraining due to platform change Non-OEM or alternate-brand equipment would: Disrupt standardized diagnostic workflow Introduce optical variability affecting diagnostic consistency Invalidate manufacturer warranties Require retraining of cytotechnologists and pathologists Undermine fleet uniformity and serviceability Warranty: Equipment shall include the manufacturer s standard warranty covering optical, mechanical, and illumination systems for a minimum of one (1) year. 6. Performance Monitoring The Government will monitor contractor performance to ensure compliance with all requirements outlined in this Statement of Work. Performance monitoring will include verification of timely delivery, proper installation, system functionality, completion of required training, and successful commissioning of the equipment in accordance with manufacturer specifications. Government representatives, including Pathology & Laboratory Medicine Service personnel and designated technical staff, will validate that the system operates as intended and meets operational and functional requirements prior to acceptance. Any deficiencies identified during delivery, installation, or operational verification shall be corrected by the Contractor at no additional cost to the Government. The Contractor shall coordinate all activities with the designated Government point of contact to ensure minimal disruption to laboratory operations and adherence to agreed installation schedules. 7. Security Requirements The C&A requirements do not apply, and the Security Accreditation package is not required for this SOW. 8. Government-Fu

Who won similar work

115 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 339112.

WinnerAwardsValueLast
Edwards Lifesciences LLC · $EW51$1.7MOct 7, 2026
VETERANS HEALTHCARE SUPPLY SOLUTIONS, INC9$559KMay 21, 2026
LOVELL GOVERNMENT SERVICES INC.7$202KJun 23, 2026
SCRIPTPRO USA INC5$1.1MSep 18, 2026
Omnicell, Inc. · $OMCL4$2.2MJul 24, 2026
TERUMO MEDICAL CORP4$121KJul 2, 2026
RADFORMATION, INC3$299KAug 28, 2026
RED ONE MEDICAL DEVICES LLC3$173KJul 14, 2026
GEO-MED, LLC3$100KJul 7, 2026
Trillamed LLC2$1.1MJul 28, 2026

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.

Latest awards

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 1 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (4 filings)
  • 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
  • $8K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 25 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.

  • 2 of the past winners are listed companies
  • 0 insider buys and 10 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.